Francesca Puggioni Discusses Asthma Care Advances at ERS 2026
In a recent interview, Francesca Puggioni shares insights on asthma management and treatment advancements from the ERS 2026 Congress.
Real-world evidence is crucial for assessing asthma treatment outcomes.
Long-term disease control is essential for preserving lung function.
Remote monitoring technologies enhance clinical decision-making.
At the European Respiratory Society (ERS) 2026 Congress, Francesca Puggioni from IRCCS Humanitas Research Hospital in Milan provided valuable insights into the evolving landscape of asthma care. This discussion highlighted the importance of integrating real-world evidence into clinical practice to improve treatment outcomes for asthma patients.
Puggioni emphasized that real-world data, derived from everyday clinical settings, plays a pivotal role in evaluating the effectiveness of asthma treatments. This includes monitoring lung function, the use of oral corticosteroids, and the potential for remission. Such evidence is vital for clinicians to make informed decisions regarding patient care and treatment strategies.
Another key point raised was the necessity of long-term disease control in asthma management. Puggioni noted that effective asthma care should not only address immediate symptoms but also focus on preventing exacerbations and safeguarding future lung function. This comprehensive approach is essential for improving the quality of life for asthma patients.
The discussion also touched on the advancements in remote monitoring technologies. Puggioni highlighted how digital tools can provide significant opportunities for enhancing patient management. However, she stressed the importance of utilizing registered and reliable medical devices to ensure that clinical decisions are based on accurate data.
Finally, Puggioni addressed the issue of comorbidities in asthma patients, explaining that a thorough assessment of overall health is crucial. Distinguishing between severe asthma and poor control due to unmanaged comorbidities is essential for effective treatment. The insights shared during this session underscore the ongoing need for innovation and research in asthma care, paving the way for improved patient outcomes in the future.




